<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="156349">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01844492</url>
  </required_header>
  <id_info>
    <org_study_id>PRO13020304</org_study_id>
    <nct_id>NCT01844492</nct_id>
  </id_info>
  <brief_title>Improving Patient and Family Centered Care in Advanced Critical Illness</brief_title>
  <acronym>PARTNER</acronym>
  <official_title>Improving Patient and Family Centered Care in Advanced Critical Illness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      One in five deaths in the U.S. occurs in or shortly after discharge from an intensive care
      unit (ICU), typically following decisions made by surrogate decision makers to forego life
      prolonging treatment. A large body of empirical research has identified deficiencies in care
      processes that contribute to three important problems: 1) family members often struggle in
      the role of surrogate, 2)leading to lasting psychological distress associated with the ICU
      experience  patients near the end of life frequently receive invasive, expensive treatment
      that is inconsistent with their values and preferences, and 3) end-of-life care is a major
      contributor to health care costs.[8, 9] Although advance care planning can prevent some
      unwanted treatment, many patients wish for a trial of intensive treatment when the prognosis
      is uncertain, and therefore it seems likely that the need for interventions to improve
      &quot;in-the-moment&quot; decisions by surrogates will persist.[10, 11]

      The long term goal of the investigators research program is to develop, test, and
      disseminate strategies to improve surrogate decision making for incapacitated patients and
      to mitigate adverse psychological outcomes among surrogates. In a pilot project, the
      investigators developed the PARTNER intervention (PAiring Re-engineered ICU Teams with
      Nurse-driven Emotional Support  and Relationship-building), an interdisciplinary
      intervention that 1) gives new responsibilities and advanced communication skills training
      to existing ICU staff  (local nurse leaders and social work members of the ICU team); 2)
      changes care &quot;defaults&quot; to ensure frequent clinician-family meetings; 3) adds protocolized,
      nurse-administered coaching and emotional support of surrogates before and during
      clinician-family meetings, and 4) increases use of palliative care services for patients
      with a poor prognosis. The investigators 2-year pilot study documented that the intervention
      is feasible, sustainable, and is associated with shorter ICU length of stay and cost
      savings. The objective of this proposal, which is the next step in pursuit of the long term
      goal, is to conduct a stepped wedge randomized controlled trial testing the PARTNER
      intervention in 5 ICUs among 1000 patients with advanced critical illness and their
      surrogates.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Hospital Anxiety and Depression Scale</measure>
    <time_frame>At 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess symptom burden of anxiety and depression in family members in a telephone interview 6 months after enrollment using the validated 14-item Hospital Anxiety and Depression scale (HADS) across treatment groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impact of Events Scale</measure>
    <time_frame>At 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess symptoms of post-traumatic stress in family members in a telephone interview 6 months after enrollment using the validated 22 item Impact of Events Scale across treatment groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decision Regret Scale</measure>
    <time_frame>At 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess Decisional Regret by family members in a telephone interview 6 months after enrollment using the validated 5 item Decision Regret Scale across treatment groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Communication (QOC) scale</measure>
    <time_frame>At 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess quality of communication in family members in a telephone interview 6 months after enrollment using the validated13 item Quality of Communication Scale across treatment groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>After-Death Bereaved Family Interview</measure>
    <time_frame>At 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess quality of end-of-life care using the After-Death Bereaved Family Interview, a validated measure completed by family after a patient's death.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-Perceived Patient-Centeredness of Care Scale</measure>
    <time_frame>At 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess Patient Centeredness of Care, using the 12-item Patient-Perceived Patient-Centeredness of Care Scale (PPPC) adapted for use by surrogates.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>At 6 months.</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess mortality using hospital records, 6 month follow-up with surrogates, and the National Death Index in cases in which participants are lost to telephone follow up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Katz Activities of Daily Living Scale</measure>
    <time_frame>At 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess functional status of the patient using the validated Katz Activities of Daily Living Scale at 6 months</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Intensive Care Unit Length of Stay</measure>
    <time_frame>Participants will be followed for duration of ICU stay, an expected average of 21 days.</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess the Intensive Care Unit length of stay.</description>
  </other_outcome>
  <other_outcome>
    <measure>health care utilization</measure>
    <time_frame>inclusive of index hospitalization and 6 months follow up</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess patient health care utilization using hospital records and through validated methods to assess utilization using standardized interviews.</description>
  </other_outcome>
  <other_outcome>
    <measure>Hospital Length of Stay</measure>
    <time_frame>Participants will be followed for duration of hosptial stay, an expected average of 4 weeks.</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess hospital length of stay.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Anxiety</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>ICU Usual Care Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>described below</description>
  </arm_group>
  <arm_group>
    <arm_group_label>The PARTNER Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>described below</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>The PARTNER Intervention</intervention_name>
    <description>In general terms, the PARTNER intervention gives 1) new leadership responsibilities and advanced communication training to the local nurse leaders and social work members of the ICU team and 2) makes systems-level changes to reliably achieve desired care practices. One PARTNER interventionist is assigned as the &quot;main support&quot; for each family, and, through detailed hand-offs and introductions, the ICU's other interventionists fill in when needed. The interdisciplinary intervention  1) gives new responsibilities and advanced communication skills training to existing ICU staff  (local nurse leaders and social work members of the ICU team); 2) changes care &quot;defaults&quot; to ensure frequent clinician-family meetings; 3) adds protocolized, nurse-administered coaching and emotional support of surrogates before and during clinician-family meetings, and 4) increases use of palliative care services for patients with a poor prognosis.</description>
    <arm_group_label>The PARTNER Intervention</arm_group_label>
    <other_name>--------------------------------------------------------------------------------</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ICU Usual Care Control</intervention_name>
    <description>The control group will receive usual care, in which the frequency and content of clinician-family communication is determined by the clinical team according to their usual practice. No study ICU has a protocolized approach to family communication and instead clinicians determine the timing and frequency of communication with families. All sites have palliative care services.</description>
    <arm_group_label>ICU Usual Care Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

          -  Surrogate decision maker for ICU patient in one of 5 UPMC ICU's

        Exclusion Criteria:

          -  Non-English Speaking

          -  Surrogate's loved one is for organ transplantation

          -  Not physically able to participate in family meeting
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Douglas B. White, MD,MAS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Douglas B. White, MD, MAS</last_name>
    <phone>412-647-8060</phone>
    <email>whitedb@upmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne-Marie Shields, MSN,RN</last_name>
    <phone>412-647-9102</phone>
    <email>shieldsa@upmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Centers</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15261</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Douglas B. White, MS, MAS</last_name>
      <phone>412-647-8060</phone>
    </contact>
    <contact_backup>
      <last_name>Anne-Marie Shields, MSN,RN</last_name>
      <phone>412-647-9102</phone>
      <email>shieldsa@upmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Douglas B. White, MD, MAS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Angus DC, Barnato AE, Linde-Zwirble WT, Weissfeld LA, Watson RS, Rickert T, Rubenfeld GD; Robert Wood Johnson Foundation ICU End-Of-Life Peer Group. Use of intensive care at the end of life in the United States: an epidemiologic study. Crit Care Med. 2004 Mar;32(3):638-43.</citation>
    <PMID>15090940</PMID>
  </reference>
  <reference>
    <citation>Prendergast TJ, Claessens MT, Luce JM. A national survey of end-of-life care for critically ill patients. Am J Respir Crit Care Med. 1998 Oct;158(4):1163-7.</citation>
    <PMID>9769276</PMID>
  </reference>
  <reference>
    <citation>Azoulay E, Pochard F, Kentish-Barnes N, Chevret S, Aboab J, Adrie C, Annane D, Bleichner G, Bollaert PE, Darmon M, Fassier T, Galliot R, Garrouste-Orgeas M, Goulenok C, Goldgran-Toledano D, Hayon J, Jourdain M, Kaidomar M, Laplace C, Larch√© J, Liotier J, Papazian L, Poisson C, Reignier J, Saidi F, Schlemmer B; FAMIREA Study Group. Risk of post-traumatic stress symptoms in family members of intensive care unit patients. Am J Respir Crit Care Med. 2005 May 1;171(9):987-94. Epub 2005 Jan 21.</citation>
    <PMID>15665319</PMID>
  </reference>
  <reference>
    <citation>Wendler D, Rid A. Systematic review: the effect on surrogates of making treatment decisions for others. Ann Intern Med. 2011 Mar 1;154(5):336-46. doi: 10.7326/0003-4819-154-5-201103010-00008. Review.</citation>
    <PMID>21357911</PMID>
  </reference>
  <reference>
    <citation>Lynn J, Teno JM, Phillips RS, Wu AW, Desbiens N, Harrold J, Claessens MT, Wenger N, Kreling B, Connors AF Jr. Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med. 1997 Jan 15;126(2):97-106.</citation>
    <PMID>9005760</PMID>
  </reference>
  <reference>
    <citation>Murphy DJ, Burrows D, Santilli S, Kemp AW, Tenner S, Kreling B, Teno J. The influence of the probability of survival on patients' preferences regarding cardiopulmonary resuscitation. N Engl J Med. 1994 Feb 24;330(8):545-9.</citation>
    <PMID>8302322</PMID>
  </reference>
  <reference>
    <citation>Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, Reding D, Harrell FE, Kussin P, Dawson NV, Connors AF Jr, Lynn J, Phillips RS. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA. 1998 Jun 3;279(21):1709-14. Erratum in: JAMA 2000 Jan 12;283(2):203.</citation>
    <PMID>9624023</PMID>
  </reference>
  <reference>
    <citation>Riley GF, Lubitz JD. Long-term trends in Medicare payments in the last year of life. Health Serv Res. 2010 Apr;45(2):565-76. doi: 10.1111/j.1475-6773.2010.01082.x. Epub 2010 Feb 9.</citation>
    <PMID>20148984</PMID>
  </reference>
  <reference>
    <citation>Hogan C, Lunney J, Gabel J, Lynn J. Medicare beneficiaries' costs of care in the last year of life. Health Aff (Millwood). 2001 Jul-Aug;20(4):188-95.</citation>
    <PMID>11463076</PMID>
  </reference>
  <reference>
    <citation>Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002 Apr 4;346(14):1061-6.</citation>
    <PMID>11932474</PMID>
  </reference>
  <reference>
    <citation>Sudore RL, Fried TR. Redefining the &quot;planning&quot; in advance care planning: preparing for end-of-life decision making. Ann Intern Med. 2010 Aug 17;153(4):256-61. doi: 10.1059/0003-4819-153-4-201008170-00008.</citation>
    <PMID>20713793</PMID>
  </reference>
  <reference>
    <citation>Schneiderman LJ, Gilmer T, Teetzel HD, Dugan DO, Blustein J, Cranford R, Briggs KB, Komatsu GI, Goodman-Crews P, Cohn F, Young EW. Effect of ethics consultations on nonbeneficial life-sustaining treatments in the intensive care setting: a randomized controlled trial. JAMA. 2003 Sep 3;290(9):1166-72.</citation>
    <PMID>12952998</PMID>
  </reference>
  <reference>
    <citation>Lautrette A, Darmon M, Megarbane B, Joly LM, Chevret S, Adrie C, Barnoud D, Bleichner G, Bruel C, Choukroun G, Curtis JR, Fieux F, Galliot R, Garrouste-Orgeas M, Georges H, Goldgran-Toledano D, Jourdain M, Loubert G, Reignier J, Saidi F, Souweine B, Vincent F, Barnes NK, Pochard F, Schlemmer B, Azoulay E. A communication strategy and brochure for relatives of patients dying in the ICU. N Engl J Med. 2007 Feb 1;356(5):469-78.</citation>
    <PMID>17267907</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 24, 2014</lastchanged_date>
  <firstreceived_date>April 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>decision making for incapacitated patients</keyword>
  <keyword>intensive care</keyword>
  <keyword>surrogate decision making</keyword>
  <keyword>patient centered care</keyword>
  <keyword>Palliative Care</keyword>
  <keyword>End of Life</keyword>
  <keyword>Quality of Communication</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
